KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $124.8 million.

  • Guardant Health's Shares Outstanding (Weighted Average) rose 142.71% to $124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.8 million, marking a year-over-year increase of 142.71%. This contributed to the annual value of $122.7 million for FY2024, which is 960.55% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Shares Outstanding (Weighted Average) is $124.8 million, which was up 142.71% from $124.1 million recorded in Q2 2025.
  • Guardant Health's Shares Outstanding (Weighted Average)'s 5-year high stood at $124.8 million during Q3 2025, with a 5-year trough of $101.0 million in Q1 2021.
  • For the 5-year period, Guardant Health's Shares Outstanding (Weighted Average) averaged around $111.4 million, with its median value being $108.8 million (2023).
  • Per our database at Business Quant, Guardant Health's Shares Outstanding (Weighted Average) surged by 79.53% in 2023 and then surged by 1855.49% in 2024.
  • Guardant Health's Shares Outstanding (Weighted Average) (Quarter) stood at $101.3 million in 2021, then increased by 0.85% to $102.2 million in 2022, then rose by 9.6% to $112.0 million in 2023, then increased by 9.61% to $122.7 million in 2024, then rose by 1.68% to $124.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $124.8 million in Q3 2025, compared to $124.1 million in Q2 2025 and $123.9 million in Q1 2025.